Back to Screener

Bruker Corporation - Common Stock (BRKR)

NASDAQ Mid Cap

Healthcare › Laboratory Analytical Instruments

$60.64
Market Cap: $9.2B
Data as of Jun 30, 2026 (TTM)

Price History

Feb 9, 2026 — Aug 19, 2026

Investment Snapshot

  • Trading 1,459% above Graham Number — above intrinsic value estimate
  • Piotroski F-Score 4/9 — moderate financial health
  • Loss-making — negative ROE of -3.6%

Bruker Corporation - Common Stock (BRKR) is a Healthcare company operating in Laboratory Analytical Instruments, listed on the NASDAQ , with a market capitalisation of $9.2 billion . Key value metrics: P/E ratio 1,461.2, P/B ratio 3.75, Piotroski F-Score 4 out of 9 (moderate financial health) .

Value Score

Key Metrics

P/E Ratio
1,461.20
3.75
EPS
$-0.59
Div. Yield
0.3%
PEG Ratio
P/S Ratio
EV/EBITDA
ROE
ROA
Gross Margin
Op. Margin
Net Margin
Debt/Equity
Current Ratio

Current vs 5-Year Average

Based on 5 years of SEC filings
Net Margin
↑ +2.1pp avg —
Gross Margin
↑ +2.1pp avg —
Operating Margin
↑ +2.1pp avg —
Return on Equity
↑ +2.1pp avg —
Debt / Equity
↑ +2.1pp avg —

Revenue & Net Income

EPS & Free Cash Flow Per Share

Financial Statements

Metric FY22 FY23 FY24
Revenue $X.XB $X.XB $X.XB
Gross Profit $X.XB $X.XB $X.XB
Operating Income $X.XB $X.XB $X.XB
Net Income $X.XB $X.XB $X.XB
EBITDA $X.XB $X.XB $X.XB
Total Assets $X.XB $X.XB $X.XB
Total Liabilities $X.XB $X.XB $X.XB
Data sourced from SEC EDGAR and Polygon.io. Methodology. View more Healthcare stocks →

Bruker Corporation - Common Stock — Fundamental Analysis Summary

Bruker Corporation - Common Stock (BRKR) is currently trading 1,459% above its Graham Number of $3.89, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 1,461.2x.

On financial health, BRKR shows a moderate Piotroski F-Score of 4/9, and negative return on equity of -3.6% (sector average: -20.1%), and manageable leverage with a debt-to-equity ratio of 0.74.

StockPik's composite Value Score for BRKR is 45/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

BRKR reports a solid gross margin of 46.2% (sector average: 37.4%) and a negative operating margin of -2.9%.

BRKR shows revenue growing at 2% year-over-year, with earnings declining at 108%.

BRKR pays a modest dividend yield of 0.3%.

Top Value Stocks in Healthcare

Symbol Price P/E Score
CGEN $2.28 6.1 100
ABEO $5.99 5.2 100
GMAB $33.45 2.2 100
EMBC $3.29 1.7 100
CRMD $8.75 3.5 100
How is the Value Score calculated?
Read our full methodology →
How is the Graham Number calculated?
Benjamin Graham's intrinsic value formula, worked examples, and how to use it →
Previous
BRID
Next
BRLS